Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer

NCT06904677 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer (CRC)
Neoadjuvant Therapy
Proteomics

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences